Two gene mutations transform harmless bacteria into a strain that could cause major epidemics

June 27, 2018, Norwegian Institute of Public Health
Two gene mutations transform harmless bacteria into a strain that could cause major epidemics
Figure 1. The map shows how the outbreak, starting in one province in northern Nigeria, spread like an epidemic to nearby provinces and the neighbouring country, Niger over the next four years. Credit: Brynildsrud et al., 2018

Since 2013, a new strain of meningococcal bacteria has spread rapidly in Niger and Nigeria, leading to large-scale outbreaks of meningitis. Analysis of the genetic material shows that with just two gene mutations, harmless bacteria transform into a strain that could cause major epidemics in these two countries.

"The study reminds us how important a fast, co-ordinated and knowledge-based response is when serious disease outbreaks occur," says Ola Brønstad Brynildsrud. He is a researcher at the Department of Infection Epidemiology and Modelling at the Norwegian Institute of Public Health and is the primary author of an article published by the Proceedings journal from the National Academy of Sciences.

"The purpose of the study was to characterise the of the new, dangerous strain of meningococcal bacterium, so that we could learn where it came from and why it was so virulent," he adds.

Type A almost eradicated after vaccination

Infectious meningitis is a common disease worldwide but especially in the so-called "meningitis belt—an area of sub-Saharan Africa. Historically, a particular group of meningococci (group A) has been dominant in the area. After vaccination against the disease began in 2010, this strain has almost disappeared.

However, meningococci with slightly different cell surfaces (serogroups) than type A can also be a problem.

Since 2013, meningitis caused by a new variant of group C meningococci has begun to cause serious disease, first in Nigeria and then in Niger. In 2015 and 2017, there were huge outbreaks with tens of thousands of cases of this often fatal disease.

Collected samples from patients

Together with the World Health Organization (WHO) and Doctors Without Borders (MSF), the Norwegian Institute of Public Health (NIPH) collected 151 samples from patients in Nigeria and Niger. The entire genome (all genetic material) from the bacteria were sequenced by the NIPH.

"Somewhat surprisingly, we found that the new group C strain was completely different from group A strains that previously circulated in this area. Instead, it was very similar to a bacterium we had isolated from a healthy carrier in Burkina Faso in 2012," says Brynildsrud.

The from the large group C outbreak in 2015 and 2017 turned out to be almost identical to the bacteria from the healthy carrier. Their distinguishing feature was that they had received two small gene groups that encoded the virulence factors, so the bacteria could cause disease.

Expected extensive gene transfer

"What is unique in our findings is how little effort is required to turn a harmless bacterium into one that can cause major epidemics. Previously, it was believed that extensive changes in the of the bacteria were necessary, but in this case we show that there were only two gene transfers between bacteria", explains Brynildsrud.

Bacteria can easily transfer genes and gene groups, and the bacterium that causes meningitis is well-known for uptake of genes from other bacteria in the surroundings. The study shows how the uptake of just two , i.e. a group of genes contributing to disease, can cause an epidemic.

The researchers can show quite accurately how the outbreak that started in a province in northern Nigeria in 2013, spread like an epidemic to nearby provinces and to neighbouring Niger during the next four years, see Figure 1. Niger managed to control this outbreak after 2015, when large-scale infectious disease control and preventive vaccination against group C were introduced.

"In Nigeria, the response was not so effective. The consequence is that 2017 was the worst year to date for provinces in Northern Nigeria, where the dangerous bacterial strain is still spreading to new areas. More than 14,000 people became ill, according to a report sent to the WHO. The capacity for diagnostics and surveillance is inadequate in northern Nigeria, so is only an estimate. This reminds us of how important fast, co-ordinated and knowledge-based responses are when deadly health crises arise," says Brynildsrud.

"Developing effective and inexpensive vaccines against all pathogenic meningococci is very important to eradicate meningitis epidemics," he adds.

Explore further: Nigeria starts vaccine drive to stop meningitis outbreak

More information: Ola Brønstad Brynildsrud et al. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1802298115

Related Stories

Nigeria starts vaccine drive to stop meningitis outbreak

April 5, 2017
Health workers in Nigeria on Wednesday began a mass vaccination programme to try to halt a mass outbreak of meningitis that has killed nearly 340 people since late last year.

Death toll in Nigeria meningitis outbreak up to 489

April 12, 2017
Health officials say Nigeria's meningitis outbreak has killed at least 489 people as of Monday.

Nigeria meningitis death toll tops 1,000

May 11, 2017
More than 1,000 people have died in an outbreak of meningitis in Nigeria, the Centre for Disease Control said Thursday, but added that the spread of the disease is slowing.

Nigeria says meningitis outbreak over, after 1,166 deaths

June 30, 2017
Nigeria's health minister has declared that the outbreak of meningitis in the country is over, but only after it killed 1,166 people, most', of' them children.

Meningitis outbreak kills nearly 270 in Nigeria: officials

March 29, 2017
Nearly 270 people, most of them children, have died in the past five months during the latest meningitis outbreak to hit Nigeria, public health officials said Wednesday.

Vaccine shortage for Nigeria meningitis outbreak

March 30, 2017
Nigeria is facing a major shortfall in vaccines to contain an outbreak of meningitis that has claimed 282 lives since November last year, senior health officials said on Thursday.

Recommended for you

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Affordable Care Act: Study finds surprising gaps in HIV care providers' knowledge

September 20, 2018
A new study has revealed surprising gaps in some HIV medical providers' knowledge of the Affordable Care Act, with more than a quarter of providers surveyed unable to say whether their state had expanded Medicaid.

Preventing a dengue outbreak at the 2020 Summer Olympics

September 20, 2018
In 2014, a dengue outbreak unexpectedly occurred in Tokyo. What does that mean for the 2020 summer Olympics and Paralympics being held in the city? Researchers report this week in PLOS Neglected Tropical Diseases that new ...

Researchers discover influenza virus doesn't replicate equally in all cells

September 19, 2018
The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year. In order to better understand this virus and how it spreads, University of Minnesota ...

Flu season forecasts could be more accurate with access to health care companies' data

September 19, 2018
In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could—if made available to researchers and public ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.